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Summary
Background:  Coronary  thrombolytic  therapy  was  ﬁrst  introduced  for  patients  with  acute  myocar-
dial infarction  (AMI)  during  the  early  1980s  in  Japan.  Several  modalities  have  been  developed
and primary  percutaneous  intervention  with  stent  is  the  current  preferred  strategy  for  patients
with AMI.
Methods  and  results:  From  May  1981  to  December  2010,  2782  patients  with  AMI  underwent  coro-
nary angiography  within  24  h  after  the  onset  of  symptoms  at  Hiroshima  City  Hospital.  Patients
were divided  into  6  groups  in  chronological  order.  Thrombolysis  was  most  frequently  performed
in the  early  1980s.  Balloon  angioplasty  became  the  most  frequent  choice  in  the  late  1980s  and
angioplasty  with  stents  in  the  late  1990s.  Final  thrombolysis  in  myocardial  infarction-3  ﬂow
was obtained  in  only  39%  in  the  early  1980s,  which  progressively  increased  to  93%  in  the  late
2000s. In-hospital  mortality  was  >10%  in  the  1980s,  which  decreased  by  half  in  the  late  1990s.
Post-infarction  angina  occurred  in  30%  in  the  early  1980s.  It  rapidly  decreased,  occurring  in  <1%
in the  2000s.  Reinfarction  occurred  in  8.8%  in  the  late  1980s  which  decreased  to  <3%  in  the
2000s. The  incidence  of  congestive  heart  failure  remained  unchanged  ranging  approximately
from 5%  to  10%  until  the  early  2000s,  which  decreased  to  2.8%  in  the  late  2000s.
Conclusion:  Over  the  past  30  years,  modality  of  reperfusion  therapy  has  changed  from  throm-
bolysis to  balloon  angioplasty  and  further  to  angioplasty  with  stents.  As  the  reperfusion  rate
increased, in-hospital  outcomes  after  AMI  have  improved.
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ntroductioncute  myocardial  infarction  (AMI)  is  a  leading  cause  of  death
n  the  western  countries  including  Japan.  It  was  1979  when
eperfusion  therapy  for  patients  with  AMI  was  ﬁrst  reported
Published by Elsevier Ltd. All rights reserved.
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Figure  1  Annual  numbers  of  patients  with  acute  myocardial
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1].  We  ﬁrst  undertook  coronary  thrombolytic  therapy  for
 patient  with  AMI  in  May  1981.  Several  modalities,  includ-
ng  thrombolysis,  balloon  angioplasty,  and  stents,  have  been
rought  into  clinical  use  and  have  shown  to  improve  out-
omes  of  patients  with  AMI  [2].  In  this  study,  we  reviewed
ur  30  years  of  experience  of  patients  with  AMI  undergoing
mergency  coronary  angiography.
ethods
tudy  patients
rom  May  1981  to  December  2010,  2782  consecutive  patients
ith  AMI  underwent  coronary  angiography  within  24  h  after
he  onset  of  symptoms  at  Hiroshima  City  Hospital,  a  ter-
iary  referral  institution  of  Hiroshima  City.  All  patients  were
ntered  into  a  prospective  registry  of  AMI  at  Hiroshima  City
ospital.  AMI  was  diagnosed  by  chest  pain  consistent  with
ngoing  myocardial  ischemia  persisting  longer  than  30  min
nd  concomitant  electrocardiographic  changes.  Serum  cre-
tine  kinase  was  measured  every  3  h  for  at  least  24  h,  and
eak  creatine  kinase  value  had  to  be  more  than  twice  the
ormal  upper  limit.  Patients  were  divided  into  6  groups
n  chronological  order:  281  patients  from  May  1981  to
ecember  1985  (early  1980s),  454  patients  from  January
986  to  December  1990  (late  1980s),  501  patients  from
anuary  1991  to  December  1995  (early  1990s),  517  patients
rom  January  1996  to  December  2000  (late  1990s),  500
atients  from  January  2001  to  December  2005  (early  2000s),
nd  529  patients  from  January  2006  to  December  2010  (late
000s).  This  study  was  approved  by  the  ethical  committee
f  human  research  of  Hiroshima  City  Hospital.
oronary  angiography  and  reperfusion  therapy
mergency  coronary  angiography  was  performed  in  a  manner
s  previously  reported  [3].  Selective  coronary  angiography
as  performed  in  multiple  projections  before  the  initiation
f  reperfusion  therapy.  Immediately  after  diagnostic  angiog-
aphy,  reperfusion  therapy  was  performed.  The  allocation  of
eperfusion  therapy  was  based  on  the  physician’s  decision.
odalities  of  reperfusion  therapy  were  categorized  into
hrombolysis,  percutaneous  coronary  intervention  (PCI),  or
ypass  surgery.  Thrombolysis  was  performed  by  intravenous
r  intracoronary  administration  of  urokinase,  pro-urokinase,
r  tissue  plasminogen  activators.  PCI  was  performed  with
adjunctive  PCI)  or  without  antecedent  thrombolysis  (pri-
ary  PCI).  PCI  was  further  categorized  to  plain  old  balloon
ngioplasty  (POBA)  and  PCI  with  stents.  PCI  with  stents
as  performed  with  bare-metal  stents  (BMS)  or  drug-eluting
tents  (DES).
All  coronary  angiograms  were  reviewed  by  2  angiog-
aphers  without  knowledge  of  the  clinical  variables.  The
erfusion  status  of  the  infarct-related  artery  was  deter-
ined  in  accordance  with  the  Thrombolysis  in  Myocardial
nfarction  (TIMI)  study  classiﬁcation  [4].  An  initially  occluded
rtery  was  deﬁned  as  the  TIMI-0  or  TIMI-1  ﬂow  before  the
nitiation  of  reperfusion  therapy.  Successful  reperfusion  was
eﬁned  as  TIMI-3  ﬂow  on  the  ﬁnal  shot  of  the  angiogra-
hy.  Patients  undergoing  bypass  surgery  were  excluded  from
his  assessment.  Multivessel  coronary  disease  was  deﬁned  as
C
T
snfarction  undergoing  coronary  angiography  at  Hiroshima  City
ospital.
75%  stenosis  in  one  or  more  vessels  remote  from  the  infarct
rtery.
n-hospital  outcomes
uring  hospital  stay,  death,  post-infarction  angina,  and  rein-
arction  were  recorded.  Death  was  deﬁned  as  all-cause
eath  from  cardiac  and  non-cardiac  origins.  Post-infarction
ngina  was  deﬁned  as  chest  pain  with  changes  in  ST-T-
egment  which  resolved  within  30  min  without  elevation  of
reatine  kinase  level.  Reinfarction  was  deﬁned  as  chest  pain,
hanges  in  ST-T-segment,  and  a  second  increase  in  crea-
ine  kinase  level  to  more  than  twice  the  normal  limit,  or
n  increase  of  >200  IU/l  over  the  previous  value  if  the  level
ad  not  dropped  to  normal.
tatistical  analysis
ategorical  data  are  reported  as  proportions  and  continuous
ata  as  mean  values  with  standard  deviations.  Statisti-
al  analysis  was  performed  with  ANOVA  for  continuous
ariables.  The  chi-square  test  was  used  for  categorical  vari-
bles.  We  used  the  JMP  statistical  package  (version  5.1  J;
AS,  Cary,  NC,  USA).  A  signiﬁcance  level  of  0.05  was  used
nd  two-tailed  tests  were  applied.
esults
aseline  characteristics
nnual  numbers  of  patients  are  shown  in  Fig.  1.  Since  the
ate  1980s,  approximately  100  patients  underwent  coronary
ngiography  for  AMI  every  year.  Temporal  trends  in  clini-
al  and  angiographical  variables  are  shown  in  Table  1.  From
he  early  1980s  to  the  late  2000s,  patients  became  older.
he  incidence  of  diabetes  and  hypertension  progressively
ncreased,  whereas  the  percentages  of  current  smokers  and
ime  to  angiography  decreased  over  time.hoice  of  reperfusion  therapy
emporal  trends  in  choice  of  reperfusion  therapy  are
hown  in  Table  2.  In  the  early  1980s,  thrombolysis  without
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Table  1  Baseline  characteristics  of  the  patients.
Variable  Early  1980s
(n  =  281)
Late  1980s
(n  =  454)
Early  1990s
(n  =  501)
Late  1990s
(n  =  517)
Early  2000s
(n  =  500)
Late  2000s
(n  =  529)
p  value
Age  (years;  SD)  59.9  (11.1)  61.5  (10.9)  62.4  (11.2)  63.0  (11.4)  65.3  (12.0)  65.7  (12.6)  <  0.001
Women 62  (22%)  87  (19%)  97  (19%)  108  (21%)  110  (22%)  114  (22%)  0.81
Hypertension  108  (38%)  179  (39%)  187  (37%)  217  (42%)  239  (48%)  313  (59%)  <0.001
Diabetes mellitus  54  (19%)  91  (20%)  125  (25%)  139  (27%)  131  (26%)  169  (32%)  <0.001
Current smoker 171  (61%)  246  (54%)  262  (52%)  251  (49%)  243  (49%)  216  (41%)  <0.001
Prior myocardial  infarction 29  (10%) 60  (13%)  66  (13%)  67  (13%)  53  (11%)  47  (9%)  0.15
Killip class  3—4  22  (8%) 33  (7%) 43  (9%)  48  (9%)  61  (12%)  56  (11%)  0.11
Time to  angiography  (h;  SD) 6.2  (4.9) 5.4  (4.7) 5.6  (5.2) 5.1  (5.1) 4.5  (4.7) 4.6  (4.9) <  0.001
Infarct related  artery 0.14
LMT  2  (1%)  7  (2%)  13  (3%)  8  (2%)  11  (2%)  9  (2%)
LAD 156  (56%)  234  (52%)  235  (47%)  256  (50%)  232  (46%)  241  (46%)
LXC 35  (12%)  62  (14%)  85  (17%)  60  (12%)  68  (14%)  74  (14%)
RCA 88  (31%)  151  (33%)  168  (34%)  193  (37%)  189  (38%)  204  (39%)
Initial TIMI  0-1  222  (79%)  337  (74%)  386  (77%)  405  (78%)  369  (74%)  383  (72%)  0.12
Multivessel coronary  disease  98  (35%)  166  (37%)  201  (40%)  213  (41%)  181  (36%)  170  (32%)  0.03
LAD, left anterior descending; LCX, left circumﬂex; LMT, left main trunk; RCA, right coronary artery; TIMI, thrombolysis in myocardial
infarction.
Table  2  Reperfusion  therapy.
Variable Early  1980s
(n  =  281)
Late  1980s
(n  =  454)
Early  1990s
(n  =  501)
Late  1990s
(n  =  517)
Early  2000s
(n  =  500)
Late  2000s
(n  =  529)
Thrombolysis  without  PCI 206  (73%)  113  (25%)  69  (14%)  20  (4%)  3  (1%)  8  (2%)
POBA 41  (15%)  185  (63%)  327  (65%)  91  (18%)  42  (8%)  32  (6%)
PCI with  stent  0  (0%)  0  (0%)  35  (7%)  367  (71%)  430  (86%)  468  (88%)
Bypass surgery 10  (4%)  15  (3%)  50  (10%)  17  (3%)  11  (2%)  13  (2%)
None 24  (9%)  41  (9%)  20  (4%)  22  (Y4%)  14  (3%)  8  (2%)
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Figure  2  Successful  reperfusion  (ﬁnal  thrombolysis  in
myocardial  infarction-3  ﬂow)  rate  in  each  period.  Successful
reperfusion  was  obtained  in  only  39%  of  the  patients.  It  gradu-
a
9
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HPCI, percutaneous coronary intervention; POBA, plain old balloon
adjunctive  PCI  was  most  frequently  performed.  Since  the
late  1980s,  PCI  became  the  most  frequent  choice  of  treat-
ment.  Since  the  late  1990s,  the  use  of  stents  increased,
whereas  the  use  of  thrombolysis  declined.  In  the  early  and
late  2000s,  >85%  of  the  patients  underwent  primary  PCI  with
stents.
Successful  reperfusion  was  obtained  in  94%  of  patients
treated  with  stent,  83%  with  POBA,  37%  with  thrombolysis,
and  50%  without  reperfusion  therapy.  Temporal  trends  in  the
incidence  of  successful  reperfusion  are  shown  in  Fig.  2.  In
the  early  1980s,  ﬁnal  TIMI-3  ﬂow  was  obtained  in  only  39%
of  the  patients.  It  progressively  increased  to  64%  in  the  late
1980s,  79%  in  the  early  1990s,  85%  in  the  late  1990s,  89%  in
the  early  2000s  and  93%  in  the  late  2000s  (p  <  0.001).
In-hospital  outcomes
Successful  reperfusion  was  associated  with  lower  in-hospital
mortality,  which  was  20.1%  in  patients  with  ﬁnal  TIMI-0
or  TIMI-1  ﬂow,  17.0%  with  ﬁnal  TIMI-2  ﬂow,  and  3.2%  with
ﬁnal  TIMI-3  ﬂow  (p  <  0.001).  In-hospital  mortality  was  3.8%
in  patients  treated  with  stents,  7.6%  with  POBA,  9.3%  with
thrombolysis,  22.4%  with  bypass  surgery,  and  14.0%  without
reperfusion  therapy.  Temporal  trends  in  in-hospital  out-
comes  are  shown  in  Table  3.  In-hospital  mortality  was  >10%
p
y
y
illy improved.  In  the  late  2000s,  successful  reperfusion  rate  was
3%. Patients  who  underwent  bypass  surgery  were  excluded.
n  the  1980s,  which  decreased  by  half  in  the  late  1990s.
owever,  it  did  not  change  thereafter.  Fig.  3  shows  tem-
oral  changes  in  in-hospital  mortality  of  patients  aged  <60
ears,  60—69  years,  and  ≥70  years.  In  patients  aged  <60
ears,  there  was  a  progressive  decline  in  in-hospital  mortal-
ty  until  the  late  2000s.  Among  patients  aged  60—69  years,
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Table  3  In-hospital  outcomes.
Variable  Early  1980s
(n  =  281)
Late  1980s
(n  =  454)
Early  1990s
(n  =  501)
Late  1990s
(n  =  517)
Early  2000s
(n  =  500)
Late  2000s
(n  =  529)
p  value
Death  30  (10.7%)  53  (11.7%)  43  (8.6%)  25  (4.8%)  18  (3.6%)  27  (5.1%)  <0.001
Post-infarction  angina  85  (30.3%)  45  (9.9%)  26  (5.2%)  17  (3.3%)  8  (1.6%)  5  (1.0%)  <0.001
Reinfarction 8  (2.9%)  40  (8.8%)  37  (7.4%)  17  (3.3%)  11  (2.2%)  14  (2.7%)  <0.001
Table  4  Cause  of  in-hospital  death.
Variable  Early  1980s
(n  =  281)
Late  1980s
(n  =  454)
Early  1990s
(n  =  501)
Late  1990s
(n  =  517)
Early  2000s
(n  =  500)
Late  2000s
(n  =  529)
Cardiac  29  (10.3%)  51  (11.2%)  37  (7.4%)  23  (4.5%)  18  (3.6%)  24  (4.5%)
Pump failure  16  (5.7%)  34  (7.5%)  18  (3.6%)  14  (2.7%)  12  (2.4%)  8  (1.5%)
Reinfarction 5  (1.8%)  5  (1.1%)  7  (1.4%)  2  (0.4%)  1  (0.2%)  1  (0.2%)
LV rupture  6  (2.1%)  7  (1.5%)  8  (1.6%)  2  (0.4%)  2  (0.4%)  6  (1.1%)
Arrhythmia 1  (0.4%)  4  (0.9%)  2  (0.4%)  3  (0.6%)  0  (0.0%)  3  (0.6%)
Others 1  (0.4%)  1  (0.2%)  2  (0.4%)  2  (0.4%)  3  (0.6%)  6  (1.1%)
Noncardiac 1  (0.4%)  1  (0.2%)  2  (0.4%)  2  (0.4%)  3  (0.6%)  6  (1.1%)
LV, left ventricular.
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Figure  3  Temporal  changes  in  in-hospital  mortality  of
patients  aged  <60  years,  60—69,  years  and  ≥70  years.  In  patients
aged <60  years,  there  was  a  progressive  decline  in  in-hospital
mortality  until  the  late  2000s.  Among  patients  aged  60—69
years,  the  decline  in  mortality  reached  a  plateau  in  the  late
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ment  of  AMI.990s. In  patients  aged  ≥70  years,  in-hospital  mortality  tended
o increase  from  the  early  2000s  to  the  late  2000s.
he  decline  in  mortality  reached  a  plateau  in  the  late  1990s.
n  patients  aged  ≥70  years,  in-hospital  mortality  tended  to
ncrease  from  the  early  2000s  to  the  late  2000s  (p  =  0.08).
auses  of  in-hospital  death  are  shown  in  Table  4.
Post-infarction  angina  occurred  in  30%  of  the  patients
n  the  early  1980s,  when  reperfusion  was  not  obtained  in
60%  of  the  patients.  It  rapidly  decreased  to  <10%  as  PCI
ecame  the  choice  of  treatment.  In  the  early  and  late  2000s
hen  primary  PCI  with  stent  was  performed  in  most  of  the
atients,  post-infarction  angina  became  very  rare,  occurring
nly  in  <1%  of  the  patients.
In the  early  1980s  when  reperfusion  therapy  was  unsuc-essful  in  most  of  the  patients,  reinfarction  occurred  in  only
.8%  of  the  patients.  As  reperfusion  rates  increased  with
he  use  of  POBA,  the  incidence  of  reinfarction  increased  to
a
p.8%  in  the  late  1980s.  It  decreased  to  <3%  as  PCI  with  stent
ecame  the  choice  of  treatment.
iscussion
n  this  study,  we  reviewed  our  30  years  of  experience  in
n-hospital  management  of  patients  with  AMI.  Reperfusion
herapy  was  ﬁrst  performed  with  thrombolysis  and  then
CI  has  taken  its  place.  Primary  PCI  with  stents  is  now
idely  used.  Although  patients  became  older  and  became
o  have  more  co-morbidity,  in-hospital  outcomes  after  AMI
rogressively  improved.  Although  these  ﬁndings  might  be
xpectable,  the  current  study  ﬁrst  showed  the  30  years’
rend  in  background,  treatment,  and  outcomes  of  patients
ith  AMI  since  the  introduction  of  reperfusion  therapy  in  a
ertiary  emergency  center  of  Japan.
Until  the  early  1980s,  there  had  been  controversy
hether  coronary  thrombus  caused  AMI  or  were  conse-
uences  of  AMI  [5].  In  1980,  DeWood  et  al.  [6]  undertook
oronary  angiography  to  deﬁne  the  prevalence  of  total
oronary  occlusion  in  the  hours  after  AMI.  They  reported
hat  total  coronary  occlusion  is  frequent  during  the  early
ours  of  AMI  and  decreases  in  frequency  during  the  initial
4  h,  suggesting  that  thrombus  formation  with  subsequent
ecanalization  is  important  in  the  evolution  of  AMI.  In  1979,
entrop  et  al.  [1]  ﬁrst  reported  successful  reperfusion  of
he  occluded  coronary  artery  with  streptokinase  in  a  patient
ith  AMI.  Since  then,  several  large  randomized  trials  have
emonstrated  that  thrombolytic  therapy  reduces  mortality
n  patients  with  suspected  AMI  [7,8]. Presently,  the  consen-
us  is  that  thrombus  formation  and  subsequent  occlusion  of
he  coronary  artery  are  the  primary  cause  of  the  develop-It was  May  26th  1981  when  one  of  the  authors  of  this
rticle  (H.S.)  ﬁrst  undertook  thrombolytic  therapy  for  a
atient  with  AMI  at  our  hospital  (Fig.  4)  [9].  Although
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Figure  4  The  ﬁrst  patient  who  underwent  thrombolytic  therapy  for  acute  myocardial  infarction  at  Hiroshima  City  Hospital.  On
May 26th  1981,  a  53-year-old  man  was  admitted  to  our  hospital  because  of  chest  pain.  Under  the  diagnosis  of  acute  myocardial
infarction, he  underwent  coronary  angiography  2.5  h  after  the  onset  of  chest  pain.  Control  angiogram  showed  a  total  occlusion  of
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intravenous  thrombolytic  therapy  is  now  adopted  when  pri-
mary  PCI  cannot  be  performed  timely,  intracoronary  or
intravenous  thrombolysis  was  commonly  performed  during
coronary  angiography  with  or  without  subsequent  PCI  in  the
1980s.  Although  successful  reperfusion  was  associated  with
a  signiﬁcant  reduction  in  deaths,  it  was  achieved  in  less
than  half  of  the  patients  undergoing  thrombolysis.  POBA
with  or  without  antecedent  thrombolysis  increased  success-
ful  reperfusion  and  decreased  in-hospital  mortality  [10,11].
However,  a  substantial  number  of  patients  still  suffered  from
re-infarction  even  after  POBA.  In  the  early  stage  of  the  intro-
duction  of  coronary  stents  that  were  approved  for  Japanese
use  in  1994,  controversy  existed  about  the  safety  of  the
use  of  stents  for  thrombotic  lesions  like  AMI.  Now,  the  efﬁ-
cacy  and  safety  of  PCI  with  stents  for  patients  with  AMI  are
quite  evident  [12,13].  In  the  early  and  late  2000s,  coronary
stents  were  used  in  more  than  90%  of  the  patients  undergo-
ing  primary  PCI.  These  ﬁndings  reﬂect  real-life  management
in  Japan  where  primary  PCI  is  commonly  performed  in  not
only  urban  but  also  rural  areas,  during  not  only  on-hour  but
also  off-hour  time.  The  Japanese  Acute  Coronary  Syndrome
Study  (JACSS)  is  a  large  multicenter  trial  conducted  in  35
medical  institutions  in  Japan  which  included  5325  consecu-
tive  patients  with  AMI  between  2001  and  2003  [14]. PCI  was
performed  as  reperfusion  therapy  in  80%  of  the  patients  and
in-hospital  mortality  was  8%.  On  the  contrary,  in  the  USA,  the
National  Registry  of  Myocardial  Infarction  (NRMI)  reported
that  primary  PCI  was  performed  in  only  43%  of  the  patients
with  AMI  eligible  for  reperfusion  therapy  and  thrombolysis
was  still  performed  in  28%  in  2006  [15].
As shown  in  previous  studies,  we  also  reported  that  the
use  of  stents  was  associated  with  higher  successful  reperfu-
sion  rates  as  compared  with  other  modalities.  Although  the
use  of  stents  was  not  different  between  the  early  and  late
2000s  (91%  vs.  93%,  p  =  0.18),  there  was  a  tendency  toward
higher  successful  reperfusion  rate  in  the  late  2000s  (90%  vs.
93%,  p  =  0.09).  This  may  be  in  part  attributable  to  routine
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p
tn  of  240,000  IU  urokinase,  successful  reperfusion  was  obtained
se  of  thrombus  aspiration  therapy  and  intracoronary  nico-
andil  injections  during  PCI  in  the  latest  period  (data  not
hown)  [16—18]. The  use  of  stents  not  only  increased  the
ate  of  successful  reperfusion  but  also  decreased  reinfarc-
ion.  Since  2004  when  DES  became  available  in  the  Japanese
arket,  we  have  been  positive  to  use  DES  for  patients  with
MI.  We  have  previously  reported  that  DES  decreased  the
ncidence  of  target  vessel  revascularization  but  there  were
o  differences  in  death,  reinfarction,  and  stent  thrombo-
is  between  DES  and  BMS  [19]. Currently,  American  Heart
ssociation/American  College  of  Cardiology  guidelines  rec-
mmend  that  it  is  reasonable  to  use  DES  as  an  alternative  to
MS  for  primary  PCI  in  ST-elevation  AMI  [20].
The  introduction  of  new  modalities  for  reperfusion  ther-
py  has  improved  in-hospital  outcomes  of  patients  with  AMI.
n  the  early  1980s,  more  than  10%  of  the  patients  died  during
ospitalization.  In-hospital  mortality  rapidly  decreased  to
%  by  the  late  1990s,  and  thereafter  it  had  plateaued.  Simi-
ar  ﬁndings  were  reported  from  the  MIYAGI-AMI  registry  study
2].  One  explanation  for  this  phenomenon  is  that  patients
ecame  older  and  had  more  co-morbidity  in  the  later  era.
n  the  late  2000s,  nearly  40%  of  the  patients  were  ≥70  years.
lthough  in-hospital  mortality  tended  to  increase  from  the
arly  2000s  to  late  2000s  in  patients  aged  ≥70  years,  it  was  at
east  in  part  attributable  to  further  advanced  age  in  the  later
eriod  among  those  patients  (77.2  ±  5.6  years  vs.  78.3  ±  5.9
ears,  p  =  0.06).  When  only  patients  aged  <70  years  were
nalyzed,  a  progressive  decrease  in  mortality  was  observed
ven  in  the  late  2000s.  In-hospital  mortality  was  2.2%  and
ardiac  deaths  occurred  only  in  0.9%  among  the  patients
ged  <70  years.  Further  decline  of  in-hospital  mortality
mong  patients  with  AMI  admitted  to  tertiary  emergency
enters  seems  to  be  difﬁcult  to  be  achieved  by  improving
n-hospital  care.  Prevention  of  death  before  hospital  admis-
ion,  reduction  of  infarct  size  for  better  quality  of  life  and
rognosis  after  hospital  discharge,  and  secondary  preven-
ion  of  recurrent  ischemic  events  should  be  the  important
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argets  to  further  improve  outcomes  of  patients  with  AMI
21—23].
tudy  limitations
his  study  suffers  from  the  limitations  of  all  retrospec-
ive  observational  analyses.  But  our  registry  is  prospective,
hich  includes  all  consecutive  patients  with  AMI  who  under-
ent  coronary  angiography  within  24  h  after  symptom  onset
t  our  hospital.  Small  sample  size  is  another  limitation  of
his  study.  Because  the  registry  forms  were  revised  several
imes  during  the  30  years  and  it  was  difﬁcult  to  review
edical  records  of  30  years  ago,  only  variables  that  were
ncluded  in  the  original  registry  form  were  used  for  this
tudy.  Therefore,  data  that  are  recently  paid  much  attention
o,  including  a  history  of  dyslipidemia,  ST-segment-elevation
n  admission,  the  use  of  thrombus  aspiration,  medications
efore  admission  or  at  discharge  and  so  on,  which  are
ncluded  in  the  latest  registry  form,  are  not  presented.  In
ddition,  because  this  registry  included  only  patients  who
nderwent  emergent  coronary  angiography,  selection  bias
ay  exist.  But  again,  it  was  difﬁcult  to  review  data  of  all
atients  with  AMI  during  this  long  study  period.
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